Source: BioPharma Dive

AVROBIO: Avrobio's road ends in reverse merger with Tim Springer-backed startup

The gene therapy developer's demise has given Tectonic Therapeutic, a GPCR-focused startup founded by the prolific biotech entrepreneur, an alternate path to the public markets.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Erik Ostrowski's photo - Interim-CEO of AVROBIO

Interim-CEO

Erik Ostrowski

CEO Approval Rating

82/100

Read more